European experiences with tolmetin in the treatment of rheumatic diseases.
D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy*; D010113:Oxyphenbutazone / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D011758:Pyrroles / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014046:Tolmetin / Q000009:adverse effects / Q000627:therapeutic use*; D014947:Wounds and Injuries / Q000188:drug therapy*
D010919:Placebos; D011758:Pyrroles; D014046:Tolmetin; D010113:Oxyphenbutazone; D007213:Indomethacin